Simcere Pharmaceutical, a manufacturer of branded generic pharmaceuticals in China, announced the terms of its IPO Thursday. The company plans to offer 15.6 million ADSs, including 3.1 million from selling shareholders, at a price range of $12.50 to $14.50. Each ADS will represent two ordinary shares. The ADSs will trade on the NYSE. Goldman Sachs is the sole bookrunner on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
